Cordarone X Intravenous 150mg/3mL Injection

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Nopērc to tagad

Aktīvā sastāvdaļa:

amiodarone hydrochloride, Quantity: 150 mg

Pieejams no:

Sanofi-Aventis Australia Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Amiodarone hydrochloride

Zāļu forma:

Injection, solution

Kompozīcija:

Excipient Ingredients: polysorbate 80; benzyl alcohol; water for injections

Ievadīšanas:

Intravenous

Vienības iepakojumā:

10x3mL, 6x3mL ampoules

Klase:

Medicine Registered

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Severe cases of tachyarrhythmias (eg. Wolff-Parkinson-White Syndrome, supraventricular, nodal and ventricular tachycardias, atrial flutter and fibrillation, ventricular fibrillation) not responding to other therapy. Treatment should be initiated in hospital. It is recommended that the patient should be regularly monitored for possible toxicity (eg. thyroid function, chest x-ray, ophthalmological examination, liver function etc.) during the entire course of therapy and for several months after discontinuation. Cordarone X intravenous may be used for treatment initiated in a hospital for severe cases of tachyarrhythmias (atrial, junctional and ventricular) not responding to other therapy and when a rapid response is required. Cordarone X intravenous should only be used where facilities exist for cardiac monitoring and defibrillation should the need arise

Produktu pārskats:

Visual Identification: Pale yellow clear solution; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Registered

Autorizācija datums:

1991-09-30

Lietošanas instrukcija

                                CORDARONE X
®
_Amiodarone hydrochloride_
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Cordarone X tablets
and injection.
It does not contain all the available
information.
It does not take the place of talking to
your doctor or pharmacist.
All medicines have risks and
benefits. In deciding to give you
Cordarone X, your doctor has
weighed the risks of you taking
Cordarone X against the benefits it
will have for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THIS
MEDICINE.
You may need to read it again.
WHAT CORDARONE X IS
USED FOR
Cordarone X is used to control a fast
or irregular heart beat.
It works by lengthening the gap
between one heart beat and the next,
helping to bring the heart rate to a
slower and more regular pace.
Cordarone X is not recommended for
use in children.
Your doctor may have prescribed this
medicine for another reason.
ASK YOUR DOCTOR OR PHARMACIST IF
YOU HAVE ANY QUESTIONS ABOUT WHY
THIS MEDICINE HAS BEEN PRESCRIBED
FOR YOU.
BEFORE YOU TAKE IT
_WHEN YOU MUST NOT USE_
_CORDARONE X_
1.
DO NOT USE CORDARONE X IF YOU
ARE ALLERGIC TO AMIODARONE OR
IODINE OR ANY OF THE INGREDIENTS
LISTED AT THE END OF THIS LEAFLET.
The symptoms of an allergic
reaction may include a rash,
itching, swelling, coughing, an
asthma attack or hayfever.
2.
DO NOT USE CORDARONE X IF YOU
ARE PREGNANT OR INTENDING TO GET
PREGNANT.
Cordarone X is best avoided in
the 3 months before getting
pregnant and during pregnancy.
This is because it can stay in the
body for several months even
after you stop taking it.
3.
DO NOT BREASTFEED IF YOU ARE
USING CORDARONE X AS IT CAN BE
FOUND IN BREAST MILK.
If you are breastfeeding,
alternative feeding arrangements
such as bottle feeding should be
made for your baby. TALK TO YOUR DOCTOR ABOUT THE
RISKS AND BENEFITS OF TAKING
CORDARONE X DURING PREGNANCY
AND BREASTFEEDING.
4.
DO NOT USE CORDARONE X IF YOU
HAVE OR HAVE HAD ANY THYROID
PROBLEMS.
5.
DO NOT USE CORDARONE X 
                                
                                Izlasiet visu dokumentu
                                
                            

Produkta apraksts

                                cor-x-ccdsv21-piv19-25nov21
Page 1 of 27
AUSTRALIAN PRODUCT INFORMATION – CORDARONE X 100
®
,
CORDARONE X 200
® AND CORDARONE X INTRAVENOUS
®
(AMIODARONE HYDROCHLORIDE)
1
NAME OF THE MEDICINE
Amiodarone hydrochloride
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
The active ingredient of the Cordarone X range of products is
amiodarone hydrochloride.
Tablets
Each 200 mg tablet of amiodarone contains approximately 75 mg organic
iodine and in the
steady state, metabolism of 300 mg amiodarone yields 9 mg/day of
iodine.
Injection
Each ampoule contains 150 mg amiodarone hydrochloride in 3 mL.
For the full list of excipients, see Section 6.1 List of excipients.
Excipient with known effect: Tablets contain Lactose monohydrate
3
PHARMACEUTICAL FORM
TABLETS
Cordarone X 100 - white to off-white biconvex tablet embossed on one
side with '100'
and 'action potential' and scored on other.
Cordarone X 200 - white to off-white biconvex tablet embossed with
'200' and 'action
potential' on one side and scored on the other.
INJECTION
Cordarone X Intravenous is a clear, pale yellow solution for
intravenous administration.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Severe cases of tachyarrhythmias (eg. Wolff-Parkinson-White Syndrome,
supraventricular,
nodal and ventricular tachyardias, atrial flutter and fibrillation,
ventricular fibrillation) not
responding to other therapy. Treatment should be initiated in
hospital. It is recommended
cor-x-ccdsv21-piv19-25nov21
Page 2 of 27
that the patient should be regularly monitored for possible toxicity
(eg. thyroid function, chest
X-ray, ophthalmological examination, liver function etc.) during the
entire course of therapy
and for several months after discontinuation.
Cordarone X Intravenous may be used for treatment initiated in a
hospital for severe cases of
tachyarrhythmias (atrial, junctional and ventricular) not responding
to other therapy and when
a rapid response is required. Cordarone X Intravenous should only be
used where facilities
exist for cardiac monitoring and defibrill
                                
                                Izlasiet visu dokumentu